![](https://endpts.com/wp-content/uploads/2024/02/AP24039626106985-scaled.jpg)
Rob Davis, Merck CEO (Jacquelyn Martin/AP Images)
Merck CEO says Keytruda is ‘not a repeatable model’
CHICAGO — Can there be another Keytruda?
Merck CEO Rob Davis, whose company makes the $25 billion-a-year cancer medicine, says it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.